According to the American Cancer Society, prostate cancer is the second-leading cause of cancer-related death in males in the United States, behind only lung cancer. Around 1 out of every 8 men will be diagnosed with prostate cancer at some point in their lives. In most cases, it is treatable, yet there are some cases where all known therapies are met with resistance and things take a turn for the worse. However, a new study involving mouse models revealed that a precursor to vitamin K can potentially slow prostate cancer growth.
Groundbreaking Study on Vitamin K and Cancer
researchers in a lab
Credit: Pexels
A recent discovery at Cold Spring Harbor Laboratory potentially offers a novel solution to the prostate cancer issue. Professor Lloyd Trotman and his team have discovered that the pro-oxidant supplement menadione reduces the development of prostate cancer in studies involving mice. Menadione is found in leafy greens and is a precursor to vitamin K. While this study itself is new, it is the result of another study that took place at the beginning of this century.
ADVERTISEMENT
Unbelievable! It’s a Pain Killer! Eliminates Pain Like an Eraser!
Crazy smoothie
How To Make TACO BRAID
Didn’t know about this!
Green, bean, and supremely Amish, this casserole is the talk of every potluck!
New York AG takes 1st step toward possibly seizing Trump’s assets as part of $464M fraud judgment
Zap flies, mosquitoes, and cockroaches super quick with this simple 3-ingredient mix
If you pour 1 cup of this ingredient you have no idea how many orchids will bloom INTERESTING FOR YOU
Discover the heating of tomorrow: more heat for five times less, and without using radiators!
